EUVIMEDEUVIMED entdecken
Leserbrief

Clinical Experience With Venetoclax‐Based Combinations for Relapsed/Refractory or MRD ‐Positive NPM1 ‐Mutated Acute Myeloid Leukemia

Matteo Piccini iD, Naseema Gangat iD, Francesco Mannelli, Barbara Scappini, Gaia Ciolli, Francesca Crupi iD, Andrea Pasquini, Jessica Caroprese, Giorgio Cannetti, Chiara Lucarelli, Silvia Querceto, Giada Rotunno und 5 weitere

American Journal of Hematology · 2026-07 · 101 (7) · 1451-1455

DOI: 10.1002/ajh.70313 ↗

Kurz gefasst

Leserbrief in der Zeitschrift American Journal of Hematology, online erschienen am 01.04.2026. Verfasst von Matteo Piccini und 16 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Department, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy. Die Arbeit nennt 12 Literaturangaben. Gefördert von: Fondo Zottola, University of Florence.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

NPM1leukemiamyeloidrefractoryrelapsevenetoclax

Autor:innen und Institutionen

  • Hematology Department, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
  • Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • PhD Course of Hematology, University of Florence, Florence, Italy.
  • CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

ORCID-Profile: Matteo Piccini, Naseema Gangat, Francesca Crupi, Paola Guglielmelli, Ayalew Tefferi

Förderung

  • Fondo Zottola, University of Florence

Zitieren

APA

Piccini, M., Gangat, N., Mannelli, F., Scappini, B., Ciolli, G., Crupi, F., Pasquini, A., Caroprese, J., Cannetti, G., Lucarelli, C., Querceto, S., Rotunno, G., Pancani, F., Bartalucci, N., Guglielmelli, P., Tefferi, A., & Vannucchi, A. M. (2026). Clinical Experience With Venetoclax‐Based Combinations for Relapsed/Refractory or MRD ‐Positive NPM1 ‐Mutated Acute Myeloid Leukemia. American Journal of Hematology, 101(7), 1451-1455. https://doi.org/10.1002/ajh.70313

Vancouver

Piccini M, Gangat N, Mannelli F, Scappini B, Ciolli G, Crupi F, et al. Clinical Experience With Venetoclax‐Based Combinations for Relapsed/Refractory or MRD ‐Positive NPM1 ‐Mutated Acute Myeloid Leukemia. American Journal of Hematology. 2026;101(7):1451-1455. doi:10.1002/ajh.70313

BibTeX
@article{Piccini2026,
  author = {Piccini, Matteo and Gangat, Naseema and Mannelli, Francesco and Scappini, Barbara and Ciolli, Gaia and Crupi, Francesca and Pasquini, Andrea and Caroprese, Jessica and Cannetti, Giorgio and Lucarelli, Chiara and Querceto, Silvia and Rotunno, Giada and Pancani, Fabiana and Bartalucci, Niccolò and Guglielmelli, Paola and Tefferi, Ayalew and Vannucchi, Alessandro Maria},
  title = {Clinical Experience With Venetoclax‐Based Combinations for Relapsed/Refractory or MRD ‐Positive NPM1 ‐Mutated Acute Myeloid Leukemia},
  journal = {American Journal of Hematology},
  year = {2026},
  volume = {101},
  number = {7},
  pages = {1451--1455},
  doi = {10.1002/ajh.70313}
}
Kostenlos starten →